Cargando…
Cross-inhibition of pathogenic agents and the host proteins they exploit
The major limitations of pathogen-directed therapies are the emergence of drug-resistance and their narrow spectrum of coverage. A recently applied approach directs therapies against host proteins exploited by pathogens in order to circumvent these limitations. However, host-oriented drugs leave the...
Autores principales: | Zilbermintz, Leeor, Leonardi, William, Tran, Sharon H., Zozaya, Josue, Mathew-Joseph, Alyssa, Liem, Spencer, Levitin, Anastasia, Martchenko, Mikhail |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5050486/ https://www.ncbi.nlm.nih.gov/pubmed/27703274 http://dx.doi.org/10.1038/srep34846 |
Ejemplares similares
-
Repurposing FDA approved drugs against the human fungal pathogen, Candida albicans
por: Kim, Kevin, et al.
Publicado: (2015) -
Bithionol blocks pathogenicity of bacterial toxins, ricin, and Zika virus
por: Leonardi, William, et al.
Publicado: (2016) -
Identification of agents effective against multiple toxins and viruses by host-oriented cell targeting
por: Zilbermintz, Leeor, et al.
Publicado: (2015) -
Drosophila melanogaster Y Chromosome Genes Affect Male Sensitivity to Microbial Infections
por: Bartolo, Gloria, et al.
Publicado: (2021) -
Identification of Bithionol, Dichlorophen, and Miconazole
as Antibacterial Agents against Acinetobacter calcoaceticus
por: Khaw, Tiffany H., et al.
Publicado: (2020)